OA15.02 Phase 1 Studies of DZD9008, an Oral Selective EGFR/HER2 Inhibitor in Advanced NSCLC with EGFR Exon20 Insertion Mutations
暂无分享，去创建一个
P. Janne | D. Camidge | M. Millward | L. Bazhenova | Z. Yang | W. Su | P. Mitchell | S. Qi | D. Brungs | L. Zheng | Y. Cheng | C. Lee | Y. Zhao | T. Yang | J.C. Yang | X. Ye | B. Gao | M. Wang | V. Zhu | J. Fang | L. Jiang | C. Deng | C. Chiu | J. Zhou | Y. Fan | K. Chen | X. Yu | W. Huang | W. Nian